【LYC 0075 交流专区】(前名 MEXTER)

icy97

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 FIRST ANNOUNCEMENT
Description	LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY")FIRST ANNOUNCEMENT PURSUANT TO THE GUIDANCE NOTE 3 OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD
The Board of Directors of LYC wishes to announce that the Company is an affected listed issuer under Guidance Note 3 ("GN3 Company") of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad ("Bursa Securities") ("Listing Requirements"). The Company has triggered the prescribed criteria pursuant to Rule 8.04 of the Listing Requirements and Rule 2.1(a) of Guidance Note 3 ("GN3") by virtue of the shareholders' equity being less than 25% of the issued share capital based on the Company's latest unaudited financial statements for the financial period ended 31 March 2025. Further details of the GN3 are set out in the attachment enclosed. This announcement is dated 30 May 2025.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3559529

Attachments LYC - GN3 (First Announcement) .pdf

icy97

Type	Announcement
Subject	AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN DISCLAIMER OF OPINION
Description	LYC HEALTHCARE BERHAD- DISCLAIMER OF OPINION ON THE AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR NEDED 31 MARCH 2025
Pursuant to Rule 9.19(38) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of LYC Healthcare Berhad ("LYC" or the "Company") wishes to announce that the Company's External Auditors, Crowe Malaysia PLT had expressed a disclaimer opinion on the Company's Audited Financial Statements for the financial year ended 31 March 2025. Please refer to the attachment for details.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3579139

Attachments LYC-Independent Auditors Report (amended).pdf